Liver Diseases Therapeutics Market Scope, Share Analysis And Growth 2025


Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the liver diseases therapeutics sector.

Liver Diseases Therapeutics Market Analysis & Forecast: 2025-2029
The liver diseases therapeutics market size has grown strongly in recent years. It will grow from $14.16 billion in 2024 to $15.18 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to high prevalence of liver diseases, alcohol consumption patterns, advancements in diagnostics, obesity and metabolic syndrome, awareness and screening programs, government initiatives for hepatitis control.

The liver diseases therapeutics market size is expected to see strong growth in the next few years. It will grow to $22.08 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to precision medicine approaches, innovations in RNA therapeutics, focus on fibrosis treatments, patient advocacy and support groups, development of vaccines for hepatitis, regulatory support for orphan drugs. Major trends in the forecast period include advancements in treatment for hepatitis c, emergence of novel therapies for liver fibrosis, exploration of immunotherapies, telemedicine and remote monitoring, focus on nutritional interventions.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp

What Are The Factors Driving The Liver Diseases Therapeutics Market?
The rising prevalence of liver diseases is expected to propel the growth of the liver disease therapeutics market going forward. Liver disease refers to any condition that has been affecting the liver. Liver disease therapeutics help in treating liver diseases through various treatments. For instance, in April 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, in 2022, the mortality rate from liver disease in individuals under 75 years old in England rose to 21.4 per 100,000 population, with males experiencing 6,664 premature deaths compared to 3,929 for females. Therefore, the rising prevalence of liver diseases drives the growth of the liver disease therapeutics market.

What Segments Are Covered In The Liver Diseases Therapeutics Market Report?
The liver diseases therapeuticsmarket covered in this report is segmented –

1) By Disease Type: Hepatitis; Non-Alcoholic Fatty Liver Disease; Alcohol-Induced; Liver Cancer
2) By Treatment: Antiviral; Vaccines; Chemotherapy; Immunosuppressive Agents; Corticosteroids
3) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users

Subsegments:
1) By Hepatitis: Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D
2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH); Simple Fatty Liver
3) By Alcohol-Induced Liver Disease: Alcoholic Hepatitis; Alcoholic Cirrhosis
4) By Liver Cancer: Hepatocellular Carcinoma (HCC); Cholangiocarcinoma

What Are The Future Trends Of The Liver Diseases Therapeutics Market?
Strategic partnerships are a key trend gaining popularity in the liver disease therapeutics market. Major companies operating in the liver diseases therapeutics market are undergoing collaborations to strengthen their position in the liver diseases therapeutics market. For instance, in January 2022, Aligos Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, collaborated with Merck & Co, a US-based company operating in liver disease therapeutics. This collaboration is to discover and develop oligonucleotide therapies for non-alcoholic steatohepatitis.

Which Are The Major Players Operating In The Global Liver Diseases Therapeutics Market?
Major companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals, Watson Pharmaceuticals Inc., AstraZeneca PLC, Gilead Sciences Inc., Endo International PLC, Alnylam Pharmaceuticals Inc., Provectus Biopharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.

View the full liver diseases therapeutics market report here:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Diseases Therapeutics Market Regional Insights:
North America was the largest region in the liver diseases therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in the liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Paperboard Packaging Market Analysis, Share And Growth By 2025 - 2034

Image
Drawing from trusted sources and expert analysis, this report helps businesses navigate the complex landscape of the paperboard packaging industry. Paperboard Packaging Market Analysis & Forecast: 2025-2029 The paperboard packaging market size has grown steadily in recent years. It will grow from $213.03 billion in 2024 to $221.76 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to sustainable packaging demand, shift from plastic to paperboard, brand preference for eco-friendly packaging, regulatory changes, cost-efficiency of paperboard. The paperboard packaging market size is expected to see strong growth in the next few years. It will grow to $296.77 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rise in convenience packaging, product protection demands, health and safety concerns, customization and branding, cost-efficiency. Major tren...
Read more

Unattended Terminals Market Scope, Size And Growth 2025

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the forecasted revenue size of the unattended terminals industry by 2029? The unattended terminals market size has grown rapidly in recent years. It will grow from $1.58 billion in 2024 to $1.76 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to the expansion of e-commerce growth, increasing smartphone integration, rising demand for contactless payments, rise in data analytics, and growth in the healthcare industry. The unattended terminals market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to growth in the retail industry, rise in smart cities, rise in digital payments, growing shift towards consumer convenience, and acc...
Read more

Freight Transport Management Market Size, Scope And Growth 2025 To 2034

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the projected value of the freight transport management market by 2029? The freight transport management market size has grown rapidly in recent years. It will grow from $27.28 billion in 2024 to $30.5 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increased globalization, growing population, increase in demand for goods and services, increase in government policies aimed at promoting global trade, and rising freight transportation. The freight transport management market size is expected to see rapid growth in the next few years. It will grow to $46.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to trade expansion, the rise of the e-commerce industry, the increasing complexity of supply chains, th...
Read more